S
GSK icon

Sachetta’s GSK GSK Stock Holding History

Sachetta’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-300
Closed -$16.6K – 1113
2026
Q1 		$16.6K Hold
300
– – 0.01% 339
2025
Q4 		$14.7K Hold
300
– – 0.01% 323
2025
Q3 		$12.9K Hold
300
– – ﹤0.01% 417
2025
Q2 		$11.5K Hold
300
– – ﹤0.01% 418
2025
Q1 		$11.6K Hold
300
– – ﹤0.01% 411
2024
Q4 		$10.1K Hold
300
– – ﹤0.01% 440
2024
Q3 		$12.3K Hold
300
– – ﹤0.01% 438
2024
Q2 		$11.9K Hold
300
– – 0.01% 409
2024
Q1 		$11.1K Hold
300
– – 0.01% 395
2023
Q4 		$11.1K Buy
+300
New +$10.8K 0.01% 395

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return

Sachetta's GSK Position: Q2 2026 in Review

Sachetta sold out of GSK (GSK) in Q2 2026, closing a stake of 300 shares — an estimated $16.6K sold.

Sachetta first reported a position in GSK in Q4 2023 and held it in 10 quarters. The position peaked at $16.6K in Q1 2026. 203 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Sachetta reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Sachetta sold 300 GSK shares in Q2 2026, an estimated $16.6K.
  • Sachetta first reported a position in GSK in Q4 2023 and held it in 10 quarters.
  • Sachetta's GSK position peaked at $16.6K in Q1 2026.
  • 203 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.